News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medical Ventures Corp. (MEV) Submits Second PMA Module to FDA


10/8/2007 11:37:04 AM

RICHMOND, BRITISH COLUMBIA--(Marketwire - Oct. 4, 2007) - MEDICAL VENTURES CORP. (TSX VENTURE:MEV) has submitted to the U.S. Food and Drug Administration the second of three modules of its pre-market approval (PMA) application for the Metricath GeminiĀ® catheter. The FDA will review the modules to determine whether the Gemini device will be approved for use in coronary arteries in the United States.

Read at Market Wired


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES